More Than Half of Cannabis Users With Parkinson’s Disease Report Clinical Benefits

Related Articles:

• Over Half of Cannabis Users with Parkinson’s Disease Report Clinical Benefits January 26, 2021 Cannabis products containing THC (tetrahydrocannabinol, the main psychoactive compound of cannabis) can be prescribed in Germany when previous therapies are unsuccessful or not tolerated, and where cannabis can be expected with not a very unlikely chance to relieve disabling symptoms. CBD (pure cannabidiol, derived directly from the hemp plant, a cousin of the marijuana plant) is available without a prescription…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – November 2020 November 30, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Monthy research review – December 2019 December 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Medical Marijuana ‘Can Help Everyone,’ Says Director at Maryland Cannabis Facility February 7, 2019 Warning the reporter accompanying him not to take any pictures, veteran horticulturalist Michael Castleman punches an electronic code and unlocks the door to Room 209, nicknamed the “Mother Room.” Photography is indeed forbidden inside this living vault, which contains 20 phenotypes of cannabis plants thriving under the glare of 25 ceramic metal halide lamps for 18 hours a day. The…
• Monthly research review – October 2019 October 31, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – November 2019 November 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Not Enough Info About Effects of Cannabis Use, Parkinson’s Foundation States May 27, 2020 A consensus statement from the Parkinson’s Foundation declares there isn’t enough data yet to draw reliable conclusions about whether medical cannabis products might be beneficial in treating Parkinson’s disease, and calls for more research. For people with Parkinson’s who choose to use such products, the statement urges caution, stressing the importance of open communication with healthcare providers, starting at low doses,…
• Monthly Research Review – September 2019 September 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during September 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study. October 15, 2019 Related ArticlesHigh exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study. Br J Clin Pharmacol. 2018 09;84(9):2000-2009 Authors: Tsai SC, Sheu SY, Chien LN, Lee HC, Yuan EJ, Yuan RY Abstract AIMS: We conducted a cohort study utilizing a nationwide health insurance database to assess the European Medicines Agency's restrictions…
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• Marijuana and Parkinson’s: What Do We Really Know? May 29, 2018 1.What’s in Marijuana?2.Marijuana Research3.Warning: Synthetic Marijuana4.Clinical Studies5.Side Effects6.Guidelines for Medical Marijuana and Parkinson’s7.ConclusionPeople with Parkinson’s disease (PD) and their physicians are both looking to answer whether medical marijuana can help manage Parkinson’s symptoms. Researchers have barely scratched the surface when it comes to marijuana and PD and previous studies are inconclusive about its potential benefits, but many people with Parkinson’s…
• Monthly Research Review: Jaunary 2020 January 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2020. The post is divided into seven parts based on the type of research: Basic biology, Disease mechanism, Clinical research, New clinical trials, Clinical trial news, Other news, and…
• What’s New in Parkinson’s: February 2021 February 26, 2021 From the “Give a Dime for Parkinson’s” campaign to adaptive DBS to an Off-Broadway production of Samuel Beckett’s “Endgame,” this month has brought an array of Parkinson’s news and initiatives. Check out some of the most important Parkinson’s articles, podcasts, research, opportunities, and living well stories happening now, and let us know if we missed anything important. Happy reading! PARKINSON’S…
• Medical Marijuana: Where Should Research Go? March 14, 2019 Earlier this month I attended the Medical Marijuana in Parkinson's Disease Conference in Denver. The conference, organized by the Parkinson's Foundation, brought together patients, physicians, researchers and industry to discuss medical marijuana and its potential benefits -- and risks -- to people with Parkinson's. The goal of the conference was to develop guidance for patients and physicians on its use…
• Medical Marijuana: Where Should Research Go? March 14, 2019 Earlier this month I attended the Medical Marijuana in Parkinson's Disease Conference in Denver. The conference, organized by the Parkinson's Foundation, brought together patients, physicians, researchers and industry to discuss medical marijuana and its potential benefits -- and risks -- to people with Parkinson's. The goal of the conference was to develop guidance for patients and physicians on its use…
• Medical Marijuana: Where Should Research Go? March 14, 2019 Earlier this month I attended the Medical Marijuana in Parkinson's Disease Conference in Denver. The conference, organized by the Parkinson's Foundation, brought together patients, physicians, researchers and industry to discuss medical marijuana and its potential benefits -- and risks -- to people with Parkinson's. The goal of the conference was to develop guidance for patients and physicians on its use…
• Medical Marijuana: Where Should Research Go? March 14, 2019 Earlier this month I attended the Medical Marijuana in Parkinson's Disease Conference in Denver. The conference, organized by the Parkinson's Foundation, brought together patients, physicians, researchers and industry to discuss medical marijuana and its potential benefits -- and risks -- to people with Parkinson's. The goal of the conference was to develop guidance for patients and physicians on its use…